Longevity education

Stay curious about aging well — without pretending to be your clinician.

Read today's research headlines, run honest calculators, keep a private record, and assemble an educational supplement protocol. Not a clinic.

Today's news Open calculators Build your protocol

Wearables

Sync your wearables. Personalize your longevity plan.

Connect Apple Watch / Apple Health, Garmin, and other wearables (Oura, Whoop, Strava when enabled). We pull steps, sleep, and training into your private record so calculators and your protocol can use recent averages. Not medical advice.

Connect your wearable Create a member record

Today's news

All headlines →

Nature Aging · 3 Sept 2026

GLP-1 receptor agonism extends median lifespan in mice

Commentary. A Nature Aging research highlight on mouse work in which GLP-1 receptor agonism was associated with a longer median lifespan. This is laboratory animal research, not a human trial and not a reason to start, stop, or change any medicine. VitaLonga does not prescribe GLP-1 drugs or sell them as longevity treatments. Educational supplement parallel (not a replacement): When headlines discuss GLP-1 medicines and aging, people often research food-first fiber or bitter-botanical “pathway support” formulas. Those are not semaglutide, not compounded GLP-1, and not a substitute for a prescribed GLP-1 drug. Mouse or marketing claims are hype until human outcome data exist. Weakly evidenced. Store: /store/glp1-pathway-support. Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.

Read at Nature Aging →

commentary
longevity
aging
research

Nature Aging · 3 Sept 2026

A consensus roadmap from the SENESCENCE2030 network towards precision senescence medicine

Commentary. Meeting report from the SENESCENCE2030 conference in Coimbra (May 2026). Researchers sketched priorities: classifying senescent cell states, standardizing biomarkers, and coordinating translation. Educational context for how the field talks about cellular aging — not a clinic visit and not a supplement protocol.

Read at Nature Aging →

commentary
aging
research

ScienceDaily · 3 Sept 2026

One immune switch may help drive aging across the body

Study (mice and human cells). Stanford Medicine researchers report in Science that tissue-resident macrophages lose the ability to clear senescent neutrophils with age. Blocking the PGE2 receptor EP2 on those macrophages in mice restored cleanup and left older animals leaner, stronger, and sharper across brain, heart, muscle, liver, and other organs. Human liver-cell data showed similar neutrophil buildup and EP2 activity with age. This is laboratory and observational tissue work, not a clinic protocol. No approved EP2-selective drug exists; NSAIDs that broadly lower prostaglandins are not a longevity prescription.

Read at ScienceDaily →